The N‐terminal CTGF fragments are reported to be a marker of the fibrotic phenotype in fibrotic diseases such as scleroderma, and both N‐terminal and C‐terminal fragments of CTGF are suggested to be more potent fibrogenic stimulators compared to the full‐length parent molecule 28. Here, CCN2 is linked to scleroderma.